The effect of contraceptive DE on the endometrial preparation in hysteroscopic polypectomy

Evaluation of the effect of contraceptive DE on the endometrial preparation in hysteroscopic polypectomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200825048515N28

Enrollment

100

Registered

2021-04-04

Start date

2021-04-20

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine polyp. Polyp of cervix uteri

Interventions

Intervention 1: First intervention group: In this group, patients will be treated with one contraceptive DE pill for one cycle from the fifth day of menstruation. The second pack of contraceptive DE w

Eligibility

Sex/Gender

Female

Age

30 Years to 45 Years

Inclusion criteria

Inclusion criteria: The ages of premenopause (30-45 year) Body mass index (BMI) between 23 and 28 kg/m2 Parity of 0-3 Polyps less than 2.5 cm

Exclusion criteria

Exclusion criteria: Contraindication of receiving Oral contraceptive (OCP) Undertreatment with hormonal drugs over the last 8 weeks (before enrollment) Having uterine and adnexal diseases including cervical and endometrial cancers Having active cervicitis and pelvic infection Having diabetes or thyroid disease

Design outcomes

Primary

Measure	Time frame
Endometrial thickness. Timepoint: Before taking the contraceptive DE and the day before surgery. Method of measurement: Transvaginal ultrasound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarahnaz Mardanian

Esfahan University of Medical Sciences

mardanian@med.mui.ac.ir+98 31 3234 6338

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026